Mondo Visione Worldwide Financial Markets Intelligence

FTSE Mondo Visione Exchanges Index:

"Shenzhen Stock Exchange · Chuangxianghui" Held Special Event On Synthetic Biology Industry To Promote The Development Of New Quality Productive Forces In Line With Local Conditions

Date 30/07/2024

Developing new quality productive forces is an inherent requirement and important focus for promoting high-quality development. The Third Plenary Session of the 20th CPC Central Committee emphasized that "high-quality development is the primary task in building China into a modern socialist country in all respects" and "we will improve the institutions and mechanisms for fostering new quality productive forces in line with local conditions". On July 24, SZSE held the 17th session of the "Chuangxianghui" event, focusing on the development of the synthetic biology industry. Representatives from listed companies in the synthetic biology field such as BGI, Chuanning Biotechnology, Kanghong Pharmaceutical, Sanyuan Biotechnology, Weiguang Biological Products, Jincheng Pharmaceutical, Huaheng Biotechnology, were invited. Representatives from Shenzhen's private equity funds for synthetic biology, China Construction Bank, as well as research institutions such as the Institute of Synthetic Biology of Shenzhen Institute of Advanced Technology of the Chinese Academy of Sciences, also attended. They discussed the development of the synthetic biology industry and how to support sci-tech self-reliance and self-strengthening at higher levels to help cultivate and strengthen new quality productive forces.

During the "Chuangxianghui" event, participants focused on topics such as the development trends of technologies related to the synthetic biology industry, how the government and capital market can support the development of new quality productive forces in synthetic biology, and how to solve issues related to industrialization and scaling. The speakers expressed their views on the development of the synthetic biology industry from different perspectives. They shared the practices, experiences, and cases of listed companies in using capital market tools to grow and develop. Additionally, they discussed the challenges and solutions in the industrialization of the synthetic biology industry.

Participants believe that synthetic biology is becoming one of the future industries that will impact human development. It is a key force in serving China's "dual-carbon" strategy and achieving sustainable development and a typical representative of new quality productive forces. It is imperative to accelerate the breakthroughs in synthetic biology technology and their industrial application. The capital market should play a more active role in supporting the development of the synthetic biology industry.

Next, SZSE will thoroughly study and implement the spirit of the Third Plenary Session of the 20th CPC Central Committee and the new "Nine National Rules". We will earnestly implement the major strategic deployment of the CPC Central Committee and the State Council, and the requirements set by the CSRC. Adhering to the fundamental purpose of serving the real economy, we will continue to build the "Chuangxianghui" brand in key areas, key industries, and key regions. We aim to establish a service hub for high-quality development with distinctive features of the Shenzhen market, build a platform for connecting scientific and technological achievements with financial capital, so as to lead the aggregation of resources towards technological innovation fields and promote the rapid formation of new quality productive forces.